IDEXX Labs (IDXX) Tops Q3 EPS by 8c; Raises FY18 EPS Outlook, Maintains FY18 Revenue Guidance, Offers Prelim. FY19 EPS/Revenue Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Idexx Laboratories, Inc. (NASDAQ: IDXX) | Delayed: 567.51 +14.03 (2.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $553.48 | 52 Week High | $117.84 | |||
| Open | $562.01 | 52 Week Low | $63.48 | |||
| Day High | $567.51 | P/E | 163.08 | |||
| Day Low | $558.39 | EPS | $3.48 | |||
| Volume | 140,417 | |||||
